This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paessler, S.
Right arrow Articles by Frolov, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paessler, S.
Right arrow Articles by Frolov, I.

 Previous Article  |  Next Article 

Journal of Virology, September 2003, p. 9278-9286, Vol. 77, No. 17
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.17.9278-9286.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Recombinant Sindbis/Venezuelan Equine Encephalitis Virus Is Highly Attenuated and Immunogenic

Slobodan Paessler,1 Rafik Z. Fayzulin,2 Michael Anishchenko,1 Ivorlyne P. Greene,1 Scott C. Weaver,1 and Ilya Frolov2*

Center for Biodefense and Emerging Infectious Diseases, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555-0609,1 Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-10192

Received 21 February 2003/ Accepted 6 June 2003

Venezuelan equine encephalitis virus (VEEV) is an important, naturally emerging zoonotic virus. VEEV was a significant human and equine pathogen for much of the past century, and recent outbreaks in Venezuela and Colombia (1995), with about 100,000 human cases, indicate that this virus still poses a serious public health threat. The live attenuated TC-83 vaccine strain of VEEV was developed in the 1960s using a traditional approach of serial passaging in tissue culture of the virulent Trinidad donkey (TrD) strain. This vaccine presents several problems, including adverse, sometimes severe reactions in many human vaccinees. The TC-83 strain also retains residual murine virulence and is lethal for suckling mice after intracerebral (i.c.) or subcutaneous (s.c.) inoculation. To overcome these negative effects, we developed a recombinant, chimeric Sindbis/VEE virus (SIN-83) that is more highly attenuated. The genome of this virus encoded the replicative enzymes and the cis-acting RNA elements derived from Sindbis virus (SINV), one of the least human-pathogenic alphaviruses. The structural proteins were derived from VEEV TC-83. The SIN-83 virus, which contained an additional adaptive mutation in the nsP2 gene, replicated efficiently in common cell lines and did not cause detectable disease in adult or suckling mice after either i.c. or s.c. inoculation. However, SIN-83-vaccinated mice were efficiently protected against challenge with pathogenic strains of VEEV. Our findings suggest that the use of the SINV genome as a vector for expression of structural proteins derived from more pathogenic, encephalitic alphaviruses is a promising strategy for alphavirus vaccine development.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1019. Phone: (409) 772-2327. Fax: (409) 772-5065. E-mail: ivfrolov{at}utmb.edu.


Journal of Virology, September 2003, p. 9278-9286, Vol. 77, No. 17
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.17.9278-9286.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Rosas, C. T., Paessler, S., Ni, H., Osterrieder, N. (2008). Protection of Mice by Equine Herpesvirus Type 1 Based Experimental Vaccine against Lethal Venezuelan Equine Encephalitis Virus Infection in the Absence of Neutralizing Antibodies. Am J Trop Med Hyg 78: 83-92 [Abstract] [Full Text]  
  • Garmashova, N., Atasheva, S., Kang, W., Weaver, S. C., Frolova, E., Frolov, I. (2007). Analysis of Venezuelan Equine Encephalitis Virus Capsid Protein Function in the Inhibition of Cellular Transcription. J. Virol. 81: 13552-13565 [Abstract] [Full Text]  
  • NI, H., YUN, N. E., ZACKS, M. A., WEAVER, S. C., TESH, R. B., DA ROSA, A. P. T., POWERS, A. M., FROLOV, I., PAESSLER, S. (2007). RECOMBINANT ALPHAVIRUSES ARE SAFE AND USEFUL SEROLOGICAL DIAGNOSTIC TOOLS. Am J Trop Med Hyg 76: 774-781 [Abstract] [Full Text]  
  • Garmashova, N., Gorchakov, R., Volkova, E., Paessler, S., Frolova, E., Frolov, I. (2007). The Old World and New World Alphaviruses Use Different Virus-Specific Proteins for Induction of Transcriptional Shutoff. J. Virol. 81: 2472-2484 [Abstract] [Full Text]  
  • Paessler, S., Ni, H., Petrakova, O., Fayzulin, R. Z., Yun, N., Anishchenko, M., Weaver, S. C., Frolov, I. (2006). Replication and Clearance of Venezuelan Equine Encephalitis Virus from the Brains of Animals Vaccinated with Chimeric SIN/VEE Viruses. J. Virol. 80: 2784-2796 [Abstract] [Full Text]  
  • WANG, E., PAESSLER, S., AGUILAR, P. V., SMITH, D. R., COFFEY, L. L., KANG, W., PFEFFER, M., OLSON, J., BLAIR, P. J., GUEVARA, C., ESTRADA-FRANCO, J., WEAVER, S. C. (2005). A NOVEL, RAPID ASSAY FOR DETECTION AND DIFFERENTIATION OF SEROTYPE-SPECIFIC ANTIBODIES TO VENEZUELAN EQUINE ENCEPHALITIS COMPLEX ALPHAVIRUSES. Am J Trop Med Hyg 72: 805-810 [Abstract] [Full Text]  
  • GREENE, I. P., PAESSLER, S., ANISHCHENKO, M., SMITH, D. R., BRAULT, A. C., FROLOV, I., WEAVER, S. C. (2005). VENEZUELAN EQUINE ENCEPHALITIS VIRUS IN THE GUINEA PIG MODEL: EVIDENCE FOR EPIZOOTIC VIRULENCE DETERMINANTS OUTSIDE THE E2 ENVELOPE GLYCOPROTEIN GENE. Am J Trop Med Hyg 72: 330-338 [Abstract] [Full Text]  
  • Fayzulin, R., Frolov, I. (2004). Changes of the Secondary Structure of the 5' End of the Sindbis Virus Genome Inhibit Virus Growth in Mosquito Cells and Lead to Accumulation of Adaptive Mutations. J. Virol. 78: 4953-4964 [Abstract] [Full Text]